Black Diamond Therapeutics, Inc. (BDTX) Ownership

$2.58

$0.02 (-0.77%)
Last update: 01:00 PM EST
Day's range
$2.54
Day's range
$2.66

Black Diamond Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/14/2025 10.40 M $16.12 M   -0.64% 18.35%
VESTAL POINT CAPITAL, LP 05/15/2025 5.60 M $8.68 M   0.00% 9.88%
NEA MANAGEMENT COMPANY, LLC 05/14/2025 4.45 M $6.90 M   0.00% 7.85%
BLACKROCK, INC. 05/02/2025 3.47 M $5.38 M   -1.32% 6.13%
BELLEVUE GROUP AG 05/14/2025 2.73 M $4.24 M   -67.91% 4.82%
VANGUARD GROUP INC 05/09/2025 2.36 M $3.65 M   -2.37% 4.16%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 2.07 M $3.21 M   0.00% 3.65%
MILLENNIUM MANAGEMENT LLC 05/15/2025 1.10 M $1.71 M   97.81% 1.95%
SIREN, L.L.C. 05/23/2025 1.05 M $1.62 M   0.00% 1.85%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 965.60 K $1.50 M   0.65% 1.70%
STATE STREET CORP 05/15/2025 867.19 K $1.34 M   -1.84% 1.53%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 572.47 K $887.61 K   -13.45% 1.01%
AWM INVESTMENT COMPANY, INC. 05/15/2025 500.00 K $775.00 K   100.00% 0.88%
GOLDMAN SACHS GROUP INC 06/27/2025 479.39 K $743.05 K   -0.92% 0.85%
MORGAN STANLEY 05/15/2025 424.36 K $657.76 K   94.64% 0.75%
NORTHERN TRUST CORP 05/13/2025 378.21 K $586.23 K   -1.19% 0.67%
FMR LLC 05/12/2025 338.67 K $524.94 K   72.68% 0.60%
J. GOLDMAN & CO LP 05/15/2025 256.50 K $397.57 K   100.00% 0.45%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 250.00 K $387.50 K   -55.29% 0.44%
STIFEL FINANCIAL CORP 05/14/2025 206.90 K $320.70 K   24.64% 0.37%
BANK OF NEW YORK MELLON CORP 04/29/2025 206.83 K $320.58 K   -0.12% 0.37%
TD ASSET MANAGEMENT INC 05/07/2025 165.68 K $256.80 K   0.00% 0.29%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2025 140.00 K $217.00 K   0.00% 0.25%
05/12/2025 135.59 K $3.33 M   100.00% 0.24%
UBS GROUP AG 05/13/2025 127.79 K $198.08 K   156.14% 0.23%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 05/14/2025 109.28 K $169.38 K   45.89% 0.19%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 109.22 K $169.30 K   0.00% 0.19%
BROWN WEALTH MANAGEMENT, LLC 05/07/2025 100.00 K $155.00 K   100.00% 0.18%
LPL FINANCIAL LLC 05/07/2025 80.24 K $124.37 K   100.00% 0.14%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 79.90 K $123.85 K   -91.16% 0.14%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 77.53 K $120.16 K   123.60% 0.14%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 73.10 K $113.31 K   -49.45% 0.13%
BARCLAYS PLC 05/15/2025 66.64 K $103.00 K   -23.00% 0.12%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2025 63.52 K $98.46 K   -85.36% 0.11%
RHUMBLINE ADVISERS 05/29/2025 54.84 K $84.99 K   -2.31% 0.10%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 54.12 K $83.89 K   100.00% 0.10%
BANK OF AMERICA CORP /DE/ 05/15/2025 46.06 K $71.39 K   -38.36% 0.08%
INVESCO LTD. 05/12/2025 45.99 K $71.28 K   152.52% 0.08%
XTX TOPCO LTD 05/08/2025 42.20 K $65.41 K   -54.09% 0.07%
RAYMOND JAMES FINANCIAL INC 05/13/2025 33.42 K $51.81 K   33.74% 0.06%
CITIGROUP INC 05/12/2025 29.97 K $46.45 K   -4.78% 0.05%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 29.79 K $46.18 K   54.78% 0.05%
HSBC HOLDINGS PLC 05/14/2025 27.13 K $42.32 K   -0.11% 0.05%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 25.75 K $39.91 K   -76.00% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 23.78 K $36.86 K   4.45% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 23.00 K $35.65 K   100.00% 0.04%
SEI INVESTMENTS CO 05/14/2025 22.80 K $35.34 K   0.00% 0.04%
SQUAREPOINT OPS LLC 05/15/2025 22.46 K $34.81 K   -82.97% 0.04%
DEUTSCHE BANK AG\ 05/09/2025 22.39 K $34.70 K   0.00% 0.04%
CITADEL ADVISORS LLC 05/15/2025 22.10 K $34.26 K   662.07% 0.04%

Black Diamond Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 108 institutional investors and hedge funds held shares of Black Diamond Therapeutics, Inc.. The most heavily invested institutionals were:

T. Rowe Price Investment Management, Inc.: 10.4 M

Vestal Point Capital, LP: 5.6 M

NEA Management Company, LLC: 4.45 M

BlackRock, Inc.: 3.47 M

Bellevue Group AG: 2.73 M

VANGUARD GROUP INC: 2.36 M

71.92% of Black Diamond Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 45.66 M shares in the last 24 months. This purchase volume represents approximately $117.80 M in transactions.